Inter-alpha Inhibitor Proteins
is developing IAIP to be the first line of defense to treat the inflammation associated with infection, injury and disease
IAIP dampens systemic inflammation as well as inflammatory processes in organs. We are targeting neuroinflammation in the brain and inflammation of the lung. The systemic anti-inflammatory effects further enhance the efficacy of our therapeutic.
INFLAMMATION IS COMPLICATED
Targeting single pathways has not yielded effective therapeutics for severe inflammatory conditions. The inflammatory response is complicated, redundant and has many different pathways
TREATMENT WITH IAIP IS A FUNDAMENTALLY NEW APPROACH
IAIP dampen multiple, diverse inflammatory pathways and play a role tissue repair. It is this broad activity that makes IAIP so effective and unique. IAIP intersect inflammatory pathways at many different points.
INTER-ALPHA INHIBITOR PROTEINS
PROVIDING MULTIPLE, ANTI INFLAMMATORY MECHANISMS THAT WORK IN CONCERT TO CONTROL INFLAMMATION